What You Should Know:
- Mount Sinai researchers have developed machine learning models that predict the
likelihood of critical events and mortality in COVID-19 patients within
clinically relevant time windows.
- The new machine learning models were outlined in a recent study published in the Journal of Medical Internet Research—could aid clinical practitioners at Mount Sinai and across the world in the care and
Read More
Coronavirus (COVID-19)
Mobile Point-of-Care Ultrasound Is Now A Frontline Warrior in Pandemic
Health authorities need to prioritize delivery and the repurposing of mobile point-of-care ultrasound machines which have proven to be reliable, affordable, and effective in saving the lives of coronavirus patients.
Most Americans are familiar with ultrasound technology from the scans done to check on the status of the fetus during pregnancy.
But far fewer are aware of how valuable mobile versions of these units have also become in America’s emergency rooms where they almost
Read More
Cleveland Clinic Develop COVID-19 Risk Prediction Model through Epic MyChart
What You Should Know:
- Cleveland Clinic develops the COVID-19 risk prediction model through Epic MyChart that is now available to health systems around the world.
- Healthcare organizations can present the clinically
validated model to patients in MyChart to assess their risk of having COVID-19.
Cleveland Clinic researchers have developed a COVID-19 risk prediction model that uses information from the patient’s comprehensive health records combined with patient-centered information
Read More
FDA Awards Eli Lilly Emergency Use Authorization for Antibody to Treat COVID-19
What You Should Know:
- Eli Lilly is awarded Emergency Use Authorization (EUA) by the FDA for its monoclonal antibody for the treatment of recently diagnosed, mild to moderate COVID-19 in high-risk patients.
- U.S. government
will allocate 300,000 doses of bamlanivimab to high-risk patients, with no
out-of-pocket costs for the medication.
The U.S. Food and Drug Administration (FDA) today granted
Emergency Use Authorization (EUA) for Eli
Lilly and Company's (NYSE: LLY)
Read More
How RPA Can Help Get COVID-19 Vaccines to High-Risk Patients First
While most of the public’s attention is focused on the horse race for an approved COVID-19 vaccine, another major hurdle lies just around the corner: the distribution of hundreds of millions of vaccine doses. In today’s highly complex and disconnected health data landscape, technologies like AI, Machine Learning, and robotic process automation (RPA) will be essential to making sure that the highest-risk patients receive the vaccine first.
Why identifying at-risk patients is
Read More
FDA Extends RCA With COTA to Explore COVID’s Effect on Cancer
What You Should Know:
- The FDA just extended its research collaboration
agreement (RCA) with COTA, specifically looking at how COVID-19 is affecting
cancer.
- With this expanded agreement, COTA and the FDA will use real-world data to explore the impact of COVID-19 and the pandemic on cancer treatment, with the opportunity to expand into other oncology questions in the future.
COTA, Inc., a healthcare technology
company that uses real-world data to bring clarity to cancer care,
Read More
COVID-19 Underscores Need for Identity Governance Administration
If you work in healthcare, chances are that the COVID-19 pandemic forced you to quickly scale up or move staff around to manage the onslaught of patients. The demand for clinicians and support staff grew alongside the spread of the virus, making organizations add clinicians or reassign employees with new or modified roles: Ambulatory nurses went down in the Emergency Department or Isolation Ward, revenue cycle folks started doing transport, and so on. In some cases, former staff or retired
Read More
Mammoth Lands 2 Major Partnerships to Use CRISPR to Solve COVID19 Testing Shortage, At Scale
What You Should Know:
- Mammoth Biosciences signs agreements
with MilliporeSigma and Hamilton company targeting commercialization of high-throughput
CRISPR-based SARS CoV-2 Test.
- These partnerships will help Mammoth bring a turnkey CRISPR-based sample-to-answer solution for commercial laboratories to enable a multi-fold increase in a testing capacity.
Mammoth
Biosciences, Inc., announced that it has signed agreements with
MilliporeSigma and Hamilton Company targeting
Read More
COVID-19 Hastens America’s Reckoning with Rural Healthcare
So long as we could say, “Healthcare is a business,” we could continue to avoid the moral and ethical choices from which such statements shield us.
But then COVID-19 came into the picture and the bottom dropped out of healthcare as a business. Hospitals and health systems are hemorrhaging money; the American Hospital Association estimates total losses will exceed $300 billion by the end of the year.
“The growing number of cases is threatening the very survival of hospitals just
Read More
CVS Health Adds 1,000 COVID-19 Rapid-Result Testing at Retail Pharmacy Locations
What You Should Know:
- CVS Health announced plans to expand COVID-19 testing
services by offering rapid-result testing at select CVS Pharmacy locations and
through the company’s return to work COVID-19 testing solution, Return Ready.
- Rapid-result tests can help to slow the spread of the virus, especially when combined with other preventive measures including social distancing and “mask-wearing” because it provides patients with the opportunity for a quick diagnosis, appropriate
Read More
